Acquisition establishes Aurora’s first presence in Pacific Northwest
SALEM, Ore.–(BUSINESS WIRE)–Aurora
Diagnostics announced today that it has acquired Pacific Pathology
Associates, a hospital-based practice providing professional and
technical pathology services to five hospitals and more than 225
physicians’ offices in 17 cities in the Willamette Valley area.
The acquisition establishes Aurora Diagnostics in the Pacific Northwest
region. Notably, this is the seventh acquisition that Aurora Diagnostics
has successfully completed since 2013 under its current management team.
With this acquisition, Aurora Diagnostics now operates 25 labs.
Pacific Pathology Associates operates one technical processing lab near
Salem Hospital. The practice provides extensive pathology services,
including surgical pathology, cytopathology, hematopathology,
immunohistochemistry, flow cytometry, fine needle aspiration, and bone
marrow aspiration and biopsy.
“We are pleased to welcome the successful team at Pacific Pathology
Associates to Aurora Diagnostics,” said Daniel D. Crowley, President,
Chairman and CEO of Aurora Diagnostics. “As the only pathology group of
its kind in the region, Pacific Pathology Associates is relied upon to
provide exceptional pathology services. We will help the group reach out
to new clients and maintain its reputation for premier inpatient and
outpatient pathology services.”
“Joining the Aurora Diagnostics team provides Pacific Pathology
Associates with additional resources and new capabilities to serve our
community,” said Clark McDonald, M.D., the Board-certified pathologist
who led the ownership group of Pacific Pathology Associates and who will
continue to lead the local lab after the transaction. “Aurora has a
reputation for affiliating with high quality labs that maintain strong
local relationships. This, together with our excellent team and unique
role in serving this community, will help make this a successful
relationship for our clients.”
This acquisition is Aurora’s fifth in the hospital laboratory sector
since 2013. Serving 85 hospitals throughout the U.S., the Company is a
leader in outsourced hospital lab management services. Additionally, its
Aurora Research Institute subsidiary is a leader in helping hospitals
and independent labs to ethically provide tissue and blood samples to
researchers on the cutting edge of research for effective cancer
“This acquisition builds on our ability to meet the needs of hospitals
in the rapidly changing healthcare environment,” said Mr. Crowley.
Terms of the transaction were not disclosed.
About Aurora Diagnostics
Aurora Diagnostics is the leading independent specialized laboratory
company focused on anatomic pathology at 25 locations in the United
States. Employing over 150 licensed physicians, Aurora Diagnostics
provides high-quality diagnostics and testing information for the
patients of its primary referral sources—dermatologists, OB/GYN
professionals, gastroenterologists, urologists, general surgeons,
oncologists, and for 85 community hospitals. For additional information
regarding Aurora Diagnostics and the services it provides, please visit
the company website at www.auroradx.com.
Halldin Public Relations
Bill Halldin, 916-781-0650